Home | News | Aussie vaccine technology ‘promising’ but risks to COVID-19 strategy were too great: study
Associate Professor Keith Chappell. Picture: Liam Kidston

Aussie vaccine technology ‘promising’ but risks to COVID-19 strategy were too great: study

Australia’s homegrown COVID-19 vaccine candidate had potential but the false positives on HIV tests were too great a hurdle to move it into further trials, a study published this week has confirmed.

Please login below to view content or register for a 4 week FREE Trial.

Membership Login

Get the news delivered straight to your inbox

Receive the top stories in our weekly newsletter Sign up now